For decades, healthcare has operated in silos. The diagnostic lab discovers a cancer mutation. The data scientist identifies a pattern. The oncologist prescribes treatment. Each brilliant in their domain. Each [...]

How the NHS is leading a global revolution in precision diagnostics The Challenge The UK healthcare system faces unprecedented pressure. Prostate cancer has overtaken breast cancer as England's most common [...]

The landscape of precision diagnostics in the United Kingdom is undergoing a fundamental transformation. As we progress through 2026, three major developments are converging to redefine how diseases are detected, [...]

UK scientists have developed a powerful genomic profiling method that can diagnose rare genetic conditions previously missed by standard tests. As the UK deepens its investment in genomic medicine in [...]

The UK’s precision medicine ecosystem continues to mature, with recent developments reinforcing a clear shift from strategy and pilot programmes toward routine clinical implementation. Across NHS policy, genomic infrastructure, and [...]

Tuberculosis remains one of the most urgent global health challenges, particularly as antimicrobial resistance continues to rise. Traditional diagnostic approaches often struggle to deliver drug-resistance information fast enough to inform [...]

The UK’s newborn genomics initiative represents a pivotal shift in how precision diagnostics is delivered, not as a specialist service, but as part of routine clinical care. Through Genomics England’s [...]

FDA Approves New IsoPSA Blood Test to Pinpoint Aggressive Prostate Cancer The FDA has approved a novel blood test called IsoPSA that helps pinpoint aggressive prostate cancer in men over [...]